The first piece of evidence that Wnt signaling is compromised in AD came from the finding that Dickkopf-1 (Dkk1), a secreted Wnt antagonist, is elevated in the brains of AD patients and AD mouse models (24, 25). Here, DKK1 is linked to Alzheimer disease.